Discovery of High-Affinity PDGF-VEGFR Interactions: Redefining RTK Dynamics

Area of Science:

• Molecular Biology
• Biochemistry
• Cancer Research

Background:

• Traditional angiogenesis research focused on single ligand-receptor families (e.g., VEGFs to VEGFRs, PDGFs to PDGFRs).
• Recent findings indicate cross-family binding, such as VEGF-PDGFR interactions, necessitating further investigation.

Purpose of the Study:

• To identify and quantify cross-family binding interactions between Platelet-Derived Growth Factors (PDGFs) and Vascular Endothelial Growth Factor Receptors (VEGFRs).
• To explore the functional implications of these novel interactions in angiogenesis and disease.

Main Methods:

• Surface Plasmon Resonance (SPR) was used to measure binding kinetics (K_D values) between various PDGF ligands and VEGFRs.
• Computational simulations were employed to predict the contribution of these cross-family interactions to VEGFR2 ligation.

Main Results:

• Quantified the kinetics of VEGF-A:PDGFRβ interaction (K_D = 340 pM).
• Discovered and quantified new PDGF:VEGFR2 interactions, including PDGF-AA:R2 (K_D = 530 nM), PDGF-AB:R2 (K_D = 110 pM), PDGF-BB:R2 (K_D = 40 nM), and PDGF-CC:R2 (K_D = 70 pM).
• Computational models predict that cross-family PDGF binding could account for up to 96% of VEGFR2 ligation in healthy and cancerous conditions.

Conclusions:

• Novel cross-family PDGF:VEGFR interactions have been identified and quantified, expanding the known mechanisms of growth factor signaling.
• These findings offer new insights into anti-angiogenic drug resistance and highlight an expanded role for PDGF-VEGFR signaling in health and disease.